Davis Andrew S.'s Form 4 filing
Silk Road Medical Inc (SILK) · filed Sep 3, 2021
- Accession no.
- 0001593968-21-002084
- Filed
- Sep 3, 2021
- Trade date
- Sep 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $387.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Andrew S.CIK 0001770191 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Common Stock | MOption exerciseAcquired | +776 | $4.73 | +$3,670.48 | 71,188 | Direct | |
| Sep 1, 2021 | Common Stock | SSaleDisposed | −776 | $59.73F2 | −$46,350.48 | 70,412 | Direct | |
| Sep 1, 2021 | Common Stock | MOption exerciseAcquired | +5,354 | $4.73 | +$25,324.42 | 75,766 | Direct | |
| Sep 1, 2021 | Common Stock | SSaleDisposed | −5,354 | $59.73F2 | −$319,794.42 | 70,412 | Direct | |
| Sep 1, 2021 | Common Stock | MOption exerciseAcquired | +194 | $6.11 | +$1,185.34 | 70,606 | Direct | |
| Sep 1, 2021 | Common Stock | SSaleDisposed | −194 | $59.73F2 | −$11,587.62 | 70,412 | Direct | |
| Sep 1, 2021 | Common Stock | SSaleDisposed | −157 | $58.89 | −$9,245.73 | 70,255 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Common Stock | MOption exerciseDisposed | −776 | $0.00 | $0 | 66,969 | Direct | |
| Sep 1, 2021 | Common Stock | MOption exerciseDisposed | −5,354 | $0.00 | $0 | 29,956 | Direct | |
| Sep 1, 2021 | Common Stock | MOption exerciseDisposed | −194 | $0.00 | $0 | 2,768 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at price ranging from $59.06 to $60.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.